Idorsia Ltd. (FWB:19T) Financings

Idorsia Ltd.

Financings

RaiseDateIn US dollars
New Notes of Idorsia Investments SARL with 12% earn-out
Announced: CHF 72M
Use of proceeds: Launch capital for TRYVIO/JERAYGO: a focused US launch and phased commercialization in Europe and Canada
Oct 29, 2026US$86.78M
Private placement of registered shares (new and treasury shares)
Closed: CHF 65.6M raised · CHF 4 a share
Buyers: Jean-Paul and Martine Clozel (Offer Shares for an aggregate amount of up to CHF 10 million)
Insiders: Founding shareholders Jean-Paul and Martine Clozel committed to buy Offer Shares at the offer price for up to CHF 10 million, with a 180-day lockup
Use of proceeds: Strengthen balance sheet, accelerate QUVIVIQ commercial trajectory, advance pipeline, and general corporate purposes
Oct 10, 2025US$81.69M
Shares (equity line)
Update: raise
Use of proceeds: To further extend the cash runway into 2027
Aug 27, 2025
New money facility
Update: CHF 150M · Warrants at CHF 1.5
Use of proceeds: Extend cash runway to mid-2026
May 21, 2025US$181.85M
Private placement of shares
Announced: private placement
Use of proceeds: Additional capital to meet its obligations
Feb 26, 2025

Read by 6ix AI from the company's releases